Covid -19, misinformation, and antimicrobial resistance

  30 November 2020

Well before covid-19, the world already faced an emergent threat of antimicrobial resistance, and many have sounded the alarm over further escalation during the pandemic. A study from the US, for example, showed that 71% of covid-19 patients received antibiotics while only 4% had true bacterial coinfection. This overuse of antibiotics may have contributed to the observed 10% increase in resistance against several classes of antibiotics (compared with 2019) at the same institution.

Further reading: BMJ
Author(s): Mehreen Arshad, Syed Faisal Mahmood, Mishal Khan, Rumina Hasan
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!